High income vs Syria: Cause of death, by non-communicable diseases, ages 60+, female
High income
79.8%
in 2021
Syria
89.1%
in 2021
High income rank
11th
Syria rank
11th
Cause of death, by non-communicable diseases, ages 60+, female over time
- High income
- Syria
How they compare
Syria currently reports 89.1% against 79.8% in High income, a difference of 9.3%.
That makes Syria's figure about 1.1 times High income's.
Across all 6 years both countries report, Syria has been ahead every year.
High income ranks 11th and Syria ranks 11th of 47 groups.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | High income | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.9% | 96.2% | 4.3% | Syria |
| 2010s | 91.3% | 94.7% | 3.4% | Syria |
| 2020s | 80.8% | 91.0% | 10.2% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, High income or Syria?
- Syria, at 89.1% against 79.8% in High income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between High income and Syria?
- 9.3%, with Syria ahead.
- How many years of comparable data are there for High income and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do High income and Syria rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- High income ranks 11th and Syria ranks 11th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.